IMA is loading

Main Financial Data 2008

Main Data: 31/12 Year 2008
Consolidated income statement (international practice in accordance with IAS/IFRS) Millions/Euro
– total revenues 547.17
– gross industrial income 214.51
– total operating cost 142.58
– operating profit 71.93
– net financial expenses 11.27
– group profit 41.81

 

Consolidated balance sheet Millions / Euro
– working capital 78.63
– non-current assets 201.56
– provision for severance indemnities and other provisions – 22.46
– net debt – 134.80
– equity pertaining to the group and minority interests 122.93

 

Other information Millions/Euro
– depreciation, amortization and impairment 17.39
– R & D costs 23.33

 

  Euro
Dividend per share 0.90

 

  No.
Employees 3,048

 

  Euro
Share capital 17,732,000

 

Main Data: 30/06 Year 2008
Consolidated income statement (international practice in accordance with IAS/IFRS) Millions/Euro
– total revenues 251.3
– gross industrial income 99.8
– total operating cost 71.2
– operating profit 28.6
– net financial expenses 2.1
– group profit 16.2

 

Consolidated balance sheet Millions/Euro
– working capital 84.7
– non-current assets 198.9
– provision for severance indemnities and other provisions – 25.6
– net debt – 164.3
– equity pertaining to the group and minority interests 93.7

 

Other information  Millions/Euro
– depreciation, amortization and impairment 7.5
– R & D costs 12.1

 

  No.
Employees 3,010

 

  Euro
Shares capital 17,732,000

 

Net Sales by Sector: Year 2008
  Millions/Euro  
tea, herbs & coffee 84.90 15.5%
pharmaceuticals packaging 324.48 59.3%
pharmaceuticals processing 137.79 25.2%
Total 547.17 100.0%

 

Net Sales by Country: Year 2008
  Millions/Euro  
E.U. (excluding Italy) 213.05 38.9%
Other European countries 50.63 9.3%
North America 97.79 17.9%
Asia & Middle East 95.25 17.4%
Other countries 59.72 10.9%
Total exports 516.44 94.4%
Italy 30.73 5.6%
Total 547.17 100.0%